Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Neurol Res ; 30(4): 366-9, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18544253

RESUMO

BACKGROUND AND PURPOSE: Lysophosphatidic acid (LPA) is released from activated platelets. Acetylsalicylate (aspirin) is the most commonly used antiplatelet drug. The purpose of this study is to observe whether treatment with acetylsalicylate decreases the LPA level in patients with ischemic cerebrovascular diseases. METHODS: We performed a study examining LPA level in fresh plasma in cases and controls enrolled in the LPA and Stroke Prevention Study. Level of LPA was assayed by measuring its inorganic phosphorus after separation by chromatography. RESULTS: An elevated LPA level was seen in cases (n = 254) with ischemic cerebrovascular disease (3.11+/- 1.55 micromol/l) compared with 136 healthy controls (1.77 +/- 1.04 micromol/l) (p < 0.001). Administration of aspirin (100 mg q.d.) for 1 month significantly lowered LPA level in patients (n = 142) (2.41 +/- 1.03 mu mol/l) compared with that before taking acetylsalicylate (4.06 +/- 1.03 micromol/l) (p < 0.001). However, the LPA level in patients (n = 36) who stopped acetylsalicylate after taking it for 1 month was re-elevated. Before and after taking acetylsalicylate for 1 month, their LPA levels were 4.23 +/- 1.15 and 1.93 +/- 0.85 micromol/l, respectively. After 1 month withdrawal, level was 3.90 +/- 1.09 micromol/l (p < 0.001 compared that before taking acetylsalicylate). CONCLUSION: Our findings support a close association between increased plasma LPA level and platelet activation. Acetylsalicylate could decrease plasma LPA levels, which may be used as a mechanism for acetylsalicylate in the prevention of ischemic stroke.


Assuntos
Aspirina/farmacologia , Plaquetas/efeitos dos fármacos , Isquemia Encefálica/sangue , Isquemia Encefálica/tratamento farmacológico , Lisofosfolipídeos/sangue , Aspirina/uso terapêutico , Biomarcadores/sangue , Plaquetas/metabolismo , Isquemia Encefálica/fisiopatologia , Regulação para Baixo/efeitos dos fármacos , Feminino , Humanos , Lisofosfolipídeos/biossíntese , Masculino , Pessoa de Meia-Idade , Fósforo/sangue , Inibidores da Agregação Plaquetária/farmacologia , Inibidores da Agregação Plaquetária/uso terapêutico , Resultado do Tratamento
2.
Zhen Ci Yan Jiu ; 32(4): 285-8, 2007 Aug.
Artigo em Zh | MEDLINE | ID: mdl-17907396

RESUMO

In the present paper, the authors review the current development of studies on mechanisms of acupuncture treatment of acute ischemic cerebral apoplexy from (1) blood rheology, (2) cerebral microcirculation, 3) metabolism of cerebral tissue, (4) cerebral electrical activity, (5) free radicals and lipid peroxidation reaction, (6) excitatory aminoacid, (7) calcium overload, (8) nitrogen monoxidum, and (9) cerebral apoptosis. Cerebral stroke includes ischemic stroke and hemorrhagic stroke. Ischemic cerebral stroke accounted for about 60%-70% of all the stroke cases. At present, the main remedies for treating acute ischemic cerebral stroke includes thrombolysis, anti-platelet aggregation, improving microcirculation and symptomatic therapy. In stroke, highlighting the efficacy of acupuncture therapy in the treatment of stroke.


Assuntos
Terapia por Acupuntura , Isquemia Encefálica/terapia , Acidente Vascular Cerebral/terapia , Doença Aguda , Apoptose , Cálcio/metabolismo , Radicais Livres , Humanos , Peroxidação de Lipídeos , Óxido Nítrico/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA